VECTRA® WB180 provides 3D whole-body imaging at Mount Sinai’s new Melanoma and Skin Cancer Center.
Canfield’s VECTRA® WB180 has been introduced at Mount Sinai Hospital as part of a larger initiative by the dermatology department to establish a new Melanoma and Skin Cancer Center. The whole-body imaging system uses AI-driven 3D-body mapping technology to track pigmented lesions on the skin’s surface. The VECTRA WB180 will assist Mount Sinai’s staff and highly trained specialists with providing patients the highest quality of care through the early detection and treatment of melanoma. In addition, Mount Sinai’s researchers will be using the VECTRA WB180 alongside other advanced technologies to explore new skin cancer therapies and research approaches.